NCT05000294 2026-02-18Atezolizumab Plus Tivozanib in Immunologically Cold Tumor TypesUniversity of FloridaPhase 1/2 Suspended29 enrolled
NCT06683846 2025-08-24Ivonescimab in the Treatment of Multiple Advanced TumorsFudan UniversityPhase 2 Recruiting400 enrolled